$GH Gaurdant Health Position Taken: 320% Gain Opportunity if @ $100 or > by July

Updated: Apr 12, 2019

UPDATED - 4/12/19

$GH is SETTING UP & BUILDING CAUSE = EFFECT, en route to retest & very likely take out the $100 century marker.

Given the aggressive volume accumulation on the upswing relative to the muted pullback volume + that GH has cultivated higher lows after a bullish-crossover occurring on both the MACD & Stochastics momentum oscillators, we see far more upside risk than downside risk in this name. Add on the fundamental tailwind of their liquid biopsy test for lung cancer patients to be included in healthcare coverage plans and you have a stock that's a very attractive acquisition target. Who remembers $KITE Pharma when we purchased it around the $70 & $80 area...buying pressure continued as it got well above $120/share...4 months later it was acquired by Gilead & the stock shot up to it's true share price value around $180/share. This stock is very likely being accumulated due to the similar parlay. Acquisition target aside, GH is now primed for significant revenue growth nonetheless.

BotTrigger Trade Alerts (2) : $GH Guardant Health bought the common stock here @ $72.54 for a 5% allocation size AND we're also buying the July 19, 2019 $80 / $100 vertical call-spread here @ $4.75 for a separate 3% allocation size. The call-spread has a maximum value of $20 which is a 320% gain opportunity so long as share price reaches @ $100 or greater than upon expiration. Please note the Breakeven & Max Loss levels that are all illustrated here on this daily chart.

We have a very strong reversal pattern that has been cultivated from this pullback cycle. This was nothing more than a digestion of gains as the stock coils up the energy for the NEXT LEG HIGHER. The technicals here are very strong & being especially complimented by the fundamental news on this stock. BofA issued their 2nd upgrade on this stock just today, and how timely they did so on today's company announcement that Guardant Health's liquid biopsy test will now be covered in health care plans: "Guardant Health's (NASDAQ:GH) liquid biopsy, Guardant360, will be a covered benefit for the members of the health plans associated with eviCore, a technology assessment company....This will increase total lung cancer coverage for Guardant360 to more than 150M Americans, including for all Medicare beneficiaries, members of Cigna, Blue Shield of California, UPMC Health Plan, BCBS FEP (Federal Employees Program), and many others."


Some of the greatest pearls shared by Jesse Livermore:

“Money is made by sitting, not trading.”

“The desire for constant action irrespective of underlying conditions is responsible for many losses in Wall Street even among the professionals, who feel that they must take home some money everyday, as though they were working for regular wages.”

“Buy right, sit tight.”

“Nobody can catch all the fluctuations.”

“There is a time for all things, but I didn’t know it. And that is precisely what beats so many men in Wall Street who are very far from being in the main sucker class. There is the plain fool, who does the wrong thing at all times everywhere, but there is the Wall Street fool, who thinks he must trade all the time. Not many can always have adequate reasons for buying and selling stocks daily – or sufficient knowledge to make his play an intelligent play.”

“It takes time to make money.”

“Don’t give me timing, give me time.”

  • stocktwits social icon
  • Twitter - Black Circle
  • Facebook - Black Circle
  • YouTube - Black Circle

513 Garden St - Studio C  |  Santa Barbara CA 93101       info@bottrigger.com  |   805-825-7777

© 2016-2019 by BotTrigger Inc.

These results are based on performance results that have certain inherent limitations. Each trade is executed in BotTrigger's S-Corp trading account in the BotTrigger portfolio managed exclusively by Mike Saad, founder & CEO of BotTrigger of Lovical Inc & MomentumStockAlerts.com Inc (umbrella corp). The performance results shown in BotTrigger's portfolio may vary at certain times of the day due to our API feeds that pull the current price of open or closed positions from Yahoo Finance.  Although BotTrigger has consistently outperformed the S&P 500 benchmark by more than 50% per annum since inception, August of 2016, no representation is being made & or promised that any account will or is likely to achieve profits or losses similar to these being shown. BotTrigger so far this 2018, is on pace to achieve it's largest annual YTD return now in it's 3rd year since inception. This performance assumption is not promised but is being communicated that so far we have achieved the highest rate of return on a YTD & YOY (year over year basis). If a majority of our trade setups fail to materialize based on our analysis or trade thesis, it is absolutely possible to close below our running 50% average if not negative. BotTrigger may & often times does  implore hedging strategies and/or stop-loss precautions in the event that the BotTrigger portfolio sustains heavy losses that might cause the cumulative net value of BotTrigger's portfolio value to near below our 50% threshhold of YTD gains. Our goal at minimum is to be up YTD by up to at least 50% or greater. In the event the net weighting of our trade allocations drops the entire portfolio value below this threshold, then triggered sell signals are generated to reduce to a sizeable position of cash.

Past performance is no guarantee of future results and may not reflect potential deductions for fees which may reduce actual realized returns. Any historical returns may not reflect actual future performance and any investor on BotTrigger may experience different results from those shown. All our trade alerts are real-time but in some cases may be delayed due to technical delays with our SMS/MMS delivery provider or the speed in which a Member's mobile carrier accepts the depository of our delivered communications and then how soon a Member's carrier may deliver that trade alert/ message to our Members. Delivery times are nearly instant from the time we click "SEND" and often delivered to Member's mobile phones within 10 to 30 seconds; but on very rare occasion that delivery might get bounced or delayed; again this is rare but it has been known to happen. There will be times that BotTrigger's communicated entry is below or above the pricing our Members may receive communication due to market delays or delays with our SMS/MMS Mobile Text delivery provider, EzTexting 

Disclaimer: Neither the SEC nor any state securities commission or regulatory authority approved, passed upon or endorsed the merits of any investment on the BotTrigger platform.

BotTrigger’s services do not constitute “crowdfunding” as described in Title III of the Jumpstart Our Business Startups Act (“JOBS Act”). BotTrigger does not accept any trading capital from Members or any respective parties with regards to BotTrigger's S-Corp under Lovical Inc & MomentumStockAlerts.com

Privacy Statement